Kintara Therapeutics (KTRA) Reports Q3 Loss of $1.83
Tweet
Share
E-mailGet Alerts KTRA Hot Sheet
Join SI Premium – FREE
Kintara Therapeutics (NASDAQ: KTRA) reported Q3 EPS of ($1.83).
For earnings history and earnings-related data on Kintara Therapeutics (KTRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- KeyBanc Upgrades Acadia Realty Trust (AKR) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
